Annals of Oncology

Contents: Volume 13, 2002 Supplement 1   [Index by Author]

Proceedings of the Fifth International Symposium on Hodgkin's Lymphoma Find articles in this issue containing these words: [Search ALL Issues] To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link. S. Wiedenmann, J. Wolf, and V. Diehl An overview of the Fifth International Symposium on Hodgkin's Lymphoma: Recent advances in basic and clinical research Ann Oncol 13: 1-3; doi:10.1093/annonc/13.S1.1 [PDF] M. Tubiana Late mortality in Hodgkin's disease: can we reduce it? Karl Musshoff Lecture 2001 Ann Oncol 13: 5-9; doi:10.1093/annonc/13.S1.5 [PDF] R. Küppers, I. Schwering, A. Bräuninger, K. Rajewsky, and M.-L. Hansmann Biology of Hodgkin's lymphoma Ann Oncol 13: 11-18; doi:10.1093/annonc/13.S1.11 [Abstract] [PDF] D. Re, T. Zander, V. Diehl, and J. Wolf Genetic instability in Hodgkin's lymphoma Ann Oncol 13: 19-22; doi:10.1093/annonc/13.S1.19 [Abstract] [PDF] R. F. Jarrett Viruses and Hodgkin's lymphoma Ann Oncol 13: 23-29; doi:10.1093/annonc/13.S1.23 [Abstract] [PDF] A. Staratschek-Jox, Y. Y. Shugart, S. S. Strom, A. Nagler, and G. M. Taylor Genetic susceptibility to Hodgkin's lymphoma and to secondary cancer: workshop report Ann Oncol 13: 30-33; doi:10.1093/annonc/13.S1.30 [Abstract] [PDF] K. M. Kelly and J. P. Perentesis Polymorphisms of drug metabolizing enzymes and markers of genotoxicity to identify patients with Hodgkin's lymphoma at risk of treatment-related complications Ann Oncol 13: 34-39; doi:10.1093/annonc/13.S1.34 [Abstract] [PDF] D. M. Lillington, I. N. M. Micallef, E. Carpenter, M. J. Neat, J. A. L. Amess, J. Matthews, N. J. Foot, T. A. Lister, B. D. Young, and A. Z. S. Rohatiner Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasia Ann Oncol 13: 40-43; doi:10.1093/annonc/13.S1.40 [Abstract] [PDF] T. Rüdiger, R. D. Gascoyne, E. S. Jaffe, D. de Jong, J. Delabie, C. De Wolf-Peeters, S. Poppema, L. Xerri, C. Gisselbrecht, S. Wiedenmann, and H. K. Müller-Hermelink Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma Ann Oncol 13: 44-51; doi:10.1093/annonc/13.S1.44 [PDF] E. Maggio, A. van den Berg, A. Diepstra, J. Kluiver, L. Visser, and S. Poppema Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues Ann Oncol 13: 52-56; doi:10.1093/annonc/13.S1.52 [Abstract] [PDF] R. Schnell, P. Borchmann, H. Schulz, and A. Engert Current strategies of antibody-based treatment in Hodgkin's disease Ann Oncol 13: 57-66; doi:10.1093/annonc/13.S1.57 [Abstract] [PDF] T. Zander, S. Wiedenmann, and J. Wolf Prognostic factors in Hodgkin's lymphoma Ann Oncol 13: 67-74; doi:10.1093/annonc/13.S1.67 [Abstract] [PDF] D. Hasenclever The disappearance of prognostic factors in Hodgkin's disease Ann Oncol 13: 75-78; doi:10.1093/annonc/13.S1.75 [Abstract] [PDF] J. Yahalom and P. Mauch The involved field is back: issues in delineating the radiation field in Hodgkin's disease Ann Oncol 13: 79-83; doi:10.1093/annonc/13.S1.79 [Abstract] [PDF] S. Wiedenmann, P. Schiller, U. Paulus, and J. Wolf Treatment of early and intermediate stage Hodgkin's lymphoma in the German Hodgkin's Lymphoma Study Group Ann Oncol 13: 84-85; doi:10.1093/annonc/13.S1.84 [PDF] P. Carde, S. Koscielny, J. Franklin, U. Axdorph, J. Raemaekers, V. Diehl, B. Aleman, O. Brosteanu, D. Hasenclever, O. Oberlin, N. Bonvin, and M. Björkholm Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity? Ann Oncol 13: 86-91; doi:10.1093/annonc/13.S1.86 [Abstract] [PDF] J. M. Connors Current clinical trials for advanced Hodgkin's lymphoma in North America: history, design and rationale Ann Oncol 13: 92-95; doi:10.1093/annonc/13.S1.92 [PDF] C. Fermé, N. Mounier, and M. Diviné Current clinical trials for the treatment of adult advanced-stage Hodgkin's disease: GELA experiences Ann Oncol 13: 96-97; doi:10.1093/annonc/13.S1.96 [Abstract] [PDF] J. Franklin and V. Diehl Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP Ann Oncol 13: 98-101; doi:10.1093/annonc/13.S1.98 [Abstract] [PDF] T. Chisesi, M. Federico, A. Levis, G. Lambertenghi Deliliers, P. G. Gobbi, G. Santini, S. Luminari, and M. Brugiatelli ABVD versus Stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial Ann Oncol 13: 102-106; doi:10.1093/annonc/13.S1.102 [Abstract] [PDF] K. M. Kelly, R. J. Hutchinson, R. Sposto, M. A. Weiner, M. A. Lones, S. L. Perkins, V. Massey, and R. Cohen Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704 Ann Oncol 13: 107-111; doi:10.1093/annonc/13.S1.107 [Abstract] [PDF] A. Josting, A. Engert, V. Diehl, and G. P. Canellos Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease Ann Oncol 13: 112-116; doi:10.1093/annonc/13.S1.112 [PDF] A. Josting, J. M. Raemakers, V. Diehl, and A. Engert New concepts for relapsed Hodgkin's disease Ann Oncol 13: 117-121; doi:10.1093/annonc/13.S1.117 [PDF] I. Avivi and A. H. Goldstone Autologous stem cell transplantation in Hodgkin's disease Ann Oncol 13: 122-127; doi:10.1093/annonc/13.S1.122 [PDF] A. Sureda and N. Schmitz Role of allogeneic stem cell transplantation in relapsed or refractory Hodgkin's disease Ann Oncol 13: 128-132; doi:10.1093/annonc/13.S1.128 [Abstract] [PDF] S. J. Proctor, J. U. Rueffer, B. Angus, K. Breuer, H. Flechtner, R. Jarrett, A. Levis, P. Taylor, and U. Tirelli Hodgkin's disease in the elderly: current status and future directions Ann Oncol 13: 133-137; doi:10.1093/annonc/13.S1.133 [PDF] Z. Blumenfeld, E. Dann, I. Avivi, R. Epelbaum, and J. M. Rowe Fertility after treatment for Hodgkin's disease Ann Oncol 13: 138-147; doi:10.1093/annonc/13.S1.138 [Abstract] [PDF] To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link. Online ISSN 1569-8041 - Print ISSN 0923-7534 Copyright © 2008 European Society for Medical Oncology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press Oxford Journals Japan American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics